Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/13/20241:51AMAlliance NewsAlliance NewsLONDON MARKET EARLY CALL: FTSE to head lower after record run
05/13/20241:49AMPR Newswire (US)Newgen Recognized in the Gartner® Market Guide for Commercial Banking Cash Management and Trade Finance Solutions 2023 Report
05/13/20241:45AMPR Newswire (US)Newgen Recognized in the Gartner® Market Guide for Commercial Banking Cash Management and Trade Finance Solutions 2023 Report
05/13/20241:45AMPR Newswire (US)BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000
05/13/20241:43AMAlliance NewsAlliance NewsGET READY: Cerillion, Diploma, Team Internet, Victrex at 0700 BST
05/13/20241:42AMAlliance NewsAlliance NewsAlliance News UK - start of day
05/13/20241:40AMBusiness WireHai Robotics Deploys Goods-to-Person Solution in L'Oréal China's First SMART Fulfillment Center
05/13/20241:30AMGlobeNewswire Inc.BGHL (GBP): NAV(s)EU:BGHSBoussard and Gavaudan Holding
05/13/20241:30AMBusiness WireOregon Therapeutics et Lantern Pharma lancent une collaboration stratégique dans le domaine de l’intelligence artificielle pour optimiser le développement du XCE853, premier candidat médicament de sa catégorie, un puissant inhibiteur...NASDAQ:LTRNLantern Pharma Inc
05/13/20241:30AMGlobeNewswire Inc.BGHL (EUR): NAV(s)EU:BGHLBoussard And Gavaudan Holding Limited
05/13/20241:30AMGlobeNewswire Inc.BGHL (GBP): NAV(s)LSE:BGHSBoussard & Gavaudan Holding Limited
05/13/20241:30AMGlobeNewswire Inc.BGHL (EUR): NAV(s)LSE:BGHLBoussard & Gavaudan Holding Limited
05/13/20241:30AMPR Newswire (US)XRP Healthcare Solidifies Presence in Uganda with Trademark Registration Success
05/13/20241:30AMPR Newswire (US)XRP Healthcare Solidifies Presence in Uganda with Trademark Registration Success
05/13/20241:29AMPR Newswire (Canada)BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000
05/13/20241:29AMPR Newswire (US)BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000
05/13/20241:16AMBusiness WireAlmirall Delivers Strong Start of 2024 – Q1 Net Sales Growth of 6.6% Overall and 18% in the European Dermatology Business, Driven by Biologics and Solid Performance of Broad Product Portfolio
05/13/20241:15AMBusiness WireThe Eurofins Network Expands Battery Testing Services, Supporting Client Acceleration of Battery InnovationNYSE:ERFEnerplus Corporation
05/13/20241:05AMAlliance NewsAlliance NewsQatarEnergy acquires stake in two Exxon-operated Egypt offshore blocksLSE:0R1MExxon Mobil Corp
05/13/20241:03AMAlliance NewsAlliance NewsMicrosoft, Amazon to invest billions in French techLSE:0R1OAmazon.com Inc
05/13/20241:03AMAlliance NewsAlliance NewsMicrosoft, Amazon to invest billions in French techLSE:0QYPMicrosoft Corp
05/13/20241:01AMGlobeNewswire Inc.Norsk Hydro: New Hydro CEO accelerating growth, value creation and sustainability to change the game for aluminiumTG:NHYLucapa Diamond Company Ltd
05/13/20241:01AMGlobeNewswire Inc.Norsk Hydro: New Hydro CEO accelerating growth, value creation and sustainability to change the game for aluminiumTG:A2R0MANorsk Hydro ASA
05/13/20241:00AMGlobeNewswire Inc.Corbion reports the progress of its € 20 million share buyback program 6 May – 10 May 2024EU:CRBNCorbion N.V.
05/13/20241:00AMGlobeNewswire Inc.Communiqué de presse : Sanofi investit plus d’un milliard d’euros supplémentaires dans la production de médicaments en France, en plus des 2,5 milliards d’euros déjà engagés dans de grands projets de souveraineté sanitaireBIT:1SANSanofi
05/13/20241:00AMGlobeNewswire Inc.Air France-KLM a remboursé les 48 millions d'euros restants d'OCEANE à échéance 2026TG:AFRAir France KLM
05/13/20241:00AMGlobeNewswire Inc.Air France-KLM a remboursé les 48 millions d'euros restants d'OCEANE à échéance 2026LSE:AIRFAir France-Klm
05/13/20241:00AMGlobeNewswire Inc.Press Release: Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereigntyBIT:SANFSanofi
05/13/20241:00AMGlobeNewswire Inc.Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)NASDAQ:SNYSanofi
05/13/20241:00AMGlobeNewswire Inc.Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)NASDAQ:REGNRegeneron Pharmaceuticals Inc